Abstract
BackgroundSince December 2019, the coronavirus disease 2019 (COVID-19) has infected more than 12,322,000 people and killed over 556,000 people worldwide. However, Differential diagnosis remains difficult for suspected cases of COVID-19 and need to be improved to reduce misdiagnosis.MethodsSixty-eight cases of suspected COVID-19 treated in Wenzhou Central Hospital from January 21 to February 20, 2020 were divided into confirmed and COVID-19-negative groups based on the results of real-time reverse transcriptase polymerase chain reaction (RT-PCR) nucleic acid testing of the novel coronavirus in throat swab specimens to compare the clinical symptoms and laboratory and imaging results between the groups.ResultsAmong suspected patients, 17 were confirmed to COVID-19-positive group and 51 were distinguished to COVID-19-negative group. Patients with reduced white blood cell (WBC) count were more common in the COVID-19-positive group than in the COVID-19-negative group (29.4% vs 3.9%, P = 0.003). Subsequently, correlation analysis indicated that there was a significant inverse correlation existed between WBC count and temperature in the COVID-19-positive patients (r = − 0.587, P = 0.003), instead of the COVID-19-negative group. But reduced lymphocyte count was no different between the two groups (47.1% vs 25.5%, P = 0.096). More common chest imaging characteristics of the confirmed COVID-19 cases by high-resolution computed tomography (HRCT) included ground-glass opacities (GGOs), multiple patchy shadows, and consolidation with bilateral involvement than COVID-19-negative group (82.4% vs 31.4%, P = 0.0002; 41.2% vs 17.6% vs P = 0.048; 76.5% vs 43.1%, P = 0.017; respectively). The rate of clustered infection was higher in COVID-19-positive group than COVID-19-negative group (64.7% vs 7.8%, P = 0.001). Through multiplex PCR nucleic acid testing, 2 cases of influenza A, 3 cases of influenza B, 2 cases of adenovirus, 2 cases of Chlamydia pneumonia, and 7 cases of Mycoplasma pneumoniae were diagnosed in the COVID-19-negative group.ConclusionsWBC count inversely correlated with the severity of fever, GGOs, multiple patchy shadows, and consolidation in chest HRCT and clustered infection are common but not specific features in the confirmed COVID-19 group. Multiplex PCR nucleic acid testing helped differential diagnosis for suspected COVID-19 cases.
Highlights
Since December 2019, the coronavirus disease 2019 (COVID-19) has infected more than 12,322,000 people and killed over 556,000 people worldwide
Criteria to confirm or rule out the diagnosis of COVID-19 was as follows [6]: Confirmed COVID-19 cases: positive real-time reverse transcriptase polymerase chain reaction (RT-PCR) SARS-CoV-2 nucleic acid testing or viral gene sequencing showing high sequence homology to known gene sequences of SARSCoV-2; COVID-19-negative cases: suspected cases with 2 consecutive negative results of respiratory pathogen nucleic acid testing. These samples were analyzed by multiplex PCR named GeXP assay for 13 common respiratory pathogens including Influenza A (Flu A), Influenza B (Flu B), Influenza A H1N1 pdm09 (09H1), influenza H3N2 (H3), human para-influenza virus (HPIV), respiratory syncytial virus (RSV), rhinovirus (HRV), adenovirus (ADV), human metapneumovirus (HMPV), human bocavirus (HBoV), human coronavirus (HCoV), Chlamydia (Ch) and Mycoplasma pneumoniae (Mp) [7]
Patients with reduced white blood cell (WBC) count were more common in the confirmed COVID-19 group than in the COVID-19-negative group (29.4% vs 3.9%, P = 0.003)
Summary
Since December 2019, the coronavirus disease 2019 (COVID-19) has infected more than 12,322,000 people and killed over 556,000 people worldwide. Differential diagnosis remains difficult for suspected cases of COVID-19 and need to be improved to reduce misdiagnosis. Since December 2019, the epidemic of pneumonia caused by novel coronavirus in China, has continued to progress [1], having infected more than 12,322,000 people and killed over 556,000 people worldwide [2]. On February 11, 2020, The International Committee on Taxonomy of Viruses officially named this severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the World Health Organization (WHO) named the disease coronavirus disease 2019 (COVID-19) [3]. Because symptoms overlap significantly with other respiratory infections like influenza, diagnosis remains difficult
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have